Skip to main content
OpenTrials
Completed

NCT Number: NCT02869191

Blood Cultures's Profitability in Intensive Care Unit

The purpose of this study is to assess the blood cultures' profitability in intensive care unit and create a validated prediction rule for extractioning in critical patients.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Hopsital Universitario de Getafe

Getafe, Madrid, 28905, Spain

About this study

Implementing a predictive rule blood cultures to determine the probability of positive or negative result, improving the profitability of the diagnostic test.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients who have been extracted blood culture sample

Exclusion criteria

  • Under-aged, pregnants, Major burns.

Treatment and study plan

Primary outcomes

  1. Percentage of positive, negative and contaminated blood cultures

    Time frame: 2 years

Secondary outcomes

  1. Percentage of positive, negative and contaminated blood cultures after training program

    Time frame: 9 months

    the effect of applying a blood culture extraction protocol is measured

Other outcomes

  1. Contamination rates of blood cultures

    Time frame: 1 year

Sponsors and collaborators

Lead sponsor

Hospital Universitario Getafe

Other

Registry information

Important dates

Study start
2012
Primary completion
2015
Study completion
2018
First posted
Aug 16, 2016
Registry last updated
Aug 8, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.